Fungal Infections, An Issue of Infectious Disease Clinics of North America, 1st Edition
Author :
By Luis Ostrosky-Zeichner, MD and Jack Sobel, MD
There have been major advances in new therapies, diagnostic tools, and strategies for treatment and prevention of fungal infections. Despite these encouraging developments, large numbers of patients are at risk for infectious diseases, and the epidem
...view more
There have been major advances in new therapies, diagnostic tools, and strategies for treatment and prevention of fungal infections. Despite these encouraging developments, large numbers of patients are at risk for infectious diseases, and the epidemiology of invasive mycoses continues to emerge. The diagnosis of these infections remains difficult, and treatment outcomes in highly immunosuppressed patients remain poor. Thus, this issue is devoted to state-of-the-art updates on fungal infections by internationally recognized authorities in this field. Some topics covered are Antifungal agents; State-of-the-art culture, identification, and resistance testing of fungal pathogens; Non-culture diagnostics in fungal disease; Contemporary strategies in the prevention and management of fungal infections; Invasive candidiasis; Invasive aspergillosis; Mucormycoses; and Cryptococcosis to name a few.
There have been major advances in new therapies, diagnostic tools, and strategies for treatment and prevention of fungal infections. Despite these encouraging developments, large numbers of patients are at risk for infectious diseases, and the epidemiology of invasive mycoses continues to emerge. The diagnosis of these infections remains difficult, and treatment outcomes in highly immunosuppressed patients remain poor. Thus, this issue is devoted to state-of-the-art updates on fungal infections by internationally recognized authorities in this field. Some topics covered are Antifungal agents; State-of-the-art culture, identification, and resistance testing of fungal pathogens; Non-culture diagnostics in fungal disease; Contemporary strategies in the prevention and management of fungal infections; Invasive candidiasis; Invasive aspergillosis; Mucormycoses; and Cryptococcosis to name a few.
Author Information
By Luis Ostrosky-Zeichner, MD, Associate Director, Infectious Diseases Fellowship, Director, Laboratory of Mycology Research, Medical Director for Epidemiology, Memorial Hermann Hospital Texas Medical Center
Professor, Infectious Diseases and Jack Sobel, MD, Division Chief, Professor, Division of Infectious Diseases, Wayne State University School of Medicine
By Luis Ostrosky-Zeichner, MD, Associate Director, Infectious Diseases Fellowship, Director, Laboratory of Mycology Research, Medical Director for Epidemiology, Memorial Hermann Hospital Texas Medical Center
Professor, Infectious Diseases and Jack Sobel, MD, Division Chief, Professor, Division of Infectious Diseases, Wayne State University School of Medicine
https://www.asia.elsevierhealth.com/fungal-infections-an-issue-of-infectious-disease-clinics-of-north-america-9780323416498.html294673Fungal Infections, An Issue of Infectious Disease Clinics of North Americahttps://www.asia.elsevierhealth.com/media/catalog/product/9/7/9780323416498_9.jpg89.24118.99USDInStock/Medicine & Surgery/Infectious Disease/Clinics/Medicine/Infectious Disease/Clinics/Clinics/Medicine/Infectious Disease/Japan Titles4335146438872550546235054666525504152598605263160<p>There have been major advances in new therapies, diagnostic tools, and strategies for treatment and prevention of fungal infections. Despite these encouraging developments, large numbers of patients are at risk for infectious diseases, and the epidemiology of invasive mycoses continues to emerge. The diagnosis of these infections remains difficult, and treatment outcomes in highly immunosuppressed patients remain poor. Thus, this issue is devoted to state-of-the-art updates on fungal infections by internationally recognized authorities in this field. Some topics covered are Antifungal agents; State-of-the-art culture, identification, and resistance testing of fungal pathogens; Non-culture diagnostics in fungal disease; Contemporary strategies in the prevention and management of fungal infections; Invasive candidiasis; Invasive aspergillosis; Mucormycoses; and Cryptococcosis to name a few. </p> <p>There have been major advances in new therapies, diagnostic tools, and strategies for treatment and prevention of fungal infections. Despite these encouraging developments, large numbers of patients are at risk for infectious diseases, and the epidemiology of invasive mycoses continues to emerge. The diagnosis of these infections remains difficult, and treatment outcomes in highly immunosuppressed patients remain poor. Thus, this issue is devoted to state-of-the-art updates on fungal infections by internationally recognized authorities in this field. Some topics covered are Antifungal agents; State-of-the-art culture, identification, and resistance testing of fungal pathogens; Non-culture diagnostics in fungal disease; Contemporary strategies in the prevention and management of fungal infections; Invasive candidiasis; Invasive aspergillosis; Mucormycoses; and Cryptococcosis to name a few. </p>00add-to-cart97803234164982016ProfessionalBy Luis Ostrosky-Zeichner, MD and Jack Sobel, MD20161Book152w x 229hElsevier0Mar 14, 2016IN STOCKBy <STRONG>Luis Ostrosky-Zeichner</STRONG>, MD, Associate Director, Infectious Diseases Fellowship, Director, Laboratory of Mycology Research, Medical Director for Epidemiology, Memorial Hermann Hospital Texas Medical Center
Professor, Infectious Diseases and <STRONG>Jack Sobel</STRONG>, MD, Division Chief, Professor, Division of Infectious Diseases, Wayne State University School of MedicineClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
